Jingcheng Huang1, Qingqing Wen2, Weiqiang Dou2, and Xianfu Luo1
1Clinical Medical School of Yangzhou University, Northern Jiangsu People’s Hospital, Yangzhou, China, Yangzhou City, China, 2GE Healthcare, MR Research China, Beijing, P.R. China, Beijing City, China
Synopsis
Keywords: Quantitative Imaging, CEST & MT, APTw
Conventional
MRI methods are difficult to reveal histologic and molecular characteristic
heterogeneity of HCC. In this study, we aimed to investigate the relationship
between APTw and Ki-67 labeling index (LI) in hepatocellular carcinoma (HCC) to
evaluate whether APTw can reflect the pathological information of HCC at the
molecular level. It was found that APTw values were significantly different between
low and high Ki-67 LI in HCC, and the AUC to distinguish high and low Ki-67 LI
was 0.794, indicating APTw imaging might be a potential molecular technique for
predicting the malignancy grade of HCC
Introduction
Hepatocellular carcinoma is one of the
leading causes of cancer-related mortality worldwide. Ki-67, a protein
associated with cellular proliferation, can predict the malignant potential of
tumors[1]. Recently, a meta-analysis showed that high Ki-67 revealed
the potential deterioration of HCC, as presented by large tumor size, multiple
tumor nodes, tumor metastasis, cirrhosis, and vein invasion[2]. Hence,
it was suggested that Ki-67 might be a biomarker for clinical deterioration and
poor prognosis in HCC.
Amide
proton transfer weighted (APTw) imaging focuses on proton exchange between
amide protons of peptides and proteins and bulk water[3,4].
APTw imaging has been extensively applied for predicting
the Ki-67 proliferation status of tumors, including meningioma, endometrial
carcinoma and rectal adenocarcinoma[5-7]. Moreover, two recent
studies showed the potential of APTw imaging in predicting the histologic grades
of HCC. Thus, we hypothesized that APTw imaging may be helpful to predict the
Ki-67 expression in hepatocellular carcinoma.
Therefore, the
purpose of this study was to explore the feasibility of APTw imaging in predicting the Ki-67 LI of hepatocellular
carcinoma.Materials and Methods
Subjects
The study was approved by the local ethical
community, and consent forms were obtained from all patients. 8 patients were categorized
into the low Ki-67 LI group (≤ 10%) and 24 patients were categorized into the high
Ki-67 LI group (> 10%). All patients received liver tumor
resection and pathological examination.
MRI
experiments
All patients underwent liver MR scanning on
a 3.0-tesla scanner (GE DISCOVERY MR750; Milwaukee, Wisconsin, USA) with a
32-channel phased-array torso coil. Before the examination, all patients
underwent fasting for 4-6 hours. Routine liver tumor scanning protocol was used,
including T2-weighted imaging, T1-weighted imaging, and diffusion-weighted
imaging.
Before contrast injection, APTw imaging was
performed with a respiratory triggered single slice spin-echo echo-planar-imaging sequence. Images at 52
frequencies were acquired, including 49 frequencies ranging from -600 to 600 Hz
with an increment of 25 Hz and 3 unsaturated images (M0). The
applied saturation power was 2µT and the saturation duration was 2000ms. Other
scan parameters were:TE=32.7ms, TR=5432ms, FOV=34cm × 26 cm, Matrix size=128 ×
128, and slice thickness=8mm. Scan time was around 2 minutes and 52 seconds.
Imaging
analysis
Magnetization
transfer ratio asymmetry (MTRasym) image at 3.5ppm was obtained for
each patient. Two radiologists with 5 and 13 experiences were
employed for data analysis. With
the reference of axial T2WI images, three circular regions of interest (ROIs) with
approximately 40-50mm2
were placed manually in the solid component of the tumor for each patient on unsaturated
M0 images. Large cystic cavities, large areas of necrosis,
calcification, hemorrhage, and large vessels were excluded from ROI selections. ROIs of tumors were copied on the MTRasym map. Then the average APTw in the three ROIs for
each radiologist was obtained for subsequent analyses.
Statistical
analysis
All
statistical analyses were performed in SPSS 23.0. The inter-class correction
coefficient (ICC) was used to evaluate the inter-observer agreement of
measuring the APTw value between two radiologists. ICC>0.75 was considered
good reproducibility. The comparisons between APTw
values for low and high Ki-67 LI groups were analyzed using the independent t test. Receiver operating
characteristic (ROC) curves were generated for MTRasym to obtain the
areas under the curve (AUC). Pearson's correlation analysis was used to investigate the association between
Ki-67 LI and APTw value.Results
Ki-67
LI of the enrolled patients ranged from 1% to 90%. The ICC of the two
observers’ measurements for the APTw value was 0.893. Pearson’s correlation
analysis showed that APTw value was positively correlated with Ki-67 LI (r=0.377,
P=0.034). The APTw value of the high
Ki-67 LI group was significantly higher than that of the low Ki-67 LI group [
(1.33±0.77) % vs (0.64±0.58) %; P=0.026]
(Fig. 1). The cut-off APTw value for differentiating low- and
high-proliferation groups was 1.24% (sensitivity, 67%; specificity, 88%; AUC,
0.794, 95%CI: 0.615, 0.916). Representative cases are shown in Fig. 2 and
Fig. 3.Discussion and conclusions
In this study, we found that high Ki-67 LI was associated with a high APTw value. Ki-67 was widely used as a proliferation and prognostic factor of HCC. HCC with high Ki-67 LI tends to be more malignant with more mobile proteins. In addition, a higher Ki-67 index indicates a higher proliferation of hepatocellular carcinoma cells and greater cell density. Thus, the APTw value of HCC patients with high Ki-67 LI may also be high. Since APTw imaging can evaluate the expression of Ki-67 in HCC, APTw could be a non-invasive imaging method for preoperative diagnosis of HCC, which can provide an objective basis for the selection of treatment methods for clinical patients with HCC.
In conclusion, this study confirmed that the APTw value and Ki-67 LI are significantly and positively correlated. APTw provides a potential method for non-invasive evaluation of the malignancy and proliferation of HCC cells. Follow-up studies with a larger patient cohort are needed to further validate the diagnostic performance of APTw.Acknowledgements
We thank
Weiqiang Dou from GE Healthcare for this valuable support on APT sequences.References
1 Lee JH,
Yoon YC, Seo SW, Choi YL, Kim HS. Soft tissue sarcoma: DWI and DCE-MRI
parameters correlate with Ki-67 labeling index. Eur Radiol.
2020;30(2):914-924.
2 Luo Y,
Ren F, Liu Y, et al. Clinicopathological and prognostic significance of high
Ki-67 labeling index in hepatocellular carcinoma patients: a
meta-analysis. Int J Clin Exp Med. 2015;8(7):10235-10247.
3 Zhou J,
Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals
of intracellular proteins and peptides to detect pH effects in MRI. Nat
Med. 2003;9(8):1085-1090.
4 Zhou J,
Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast
for imaging of brain tumors. Magn Reson Med. 2003;50(6):1120-1126.
5 Li L,
Chen W, Yan Z, et al. Comparative Analysis of Amide Proton Transfer MRI and
Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal
Adenocarcinoma. J Magn Reson Imaging. 2020;52(5):1487-1496.
6 Ochiai
R, Mukuda N, Yunaga H, Kitao S, Okuda K, Sato S, Oishi T, Miyoshi M, Nozaki A,
Fujii S. Amide proton transfer imaging in differentiation of type II and type I
endometrial carcinoma: a pilot study. Jpn J Radiol. 2022 Feb;40(2):184-191.
7 Yu H, Wen X, Wu P, et al. Can amide proton
transfer-weighted imaging differentiate tumor grade and predict Ki-67
proliferation status of meningioma?. Eur Radiol. 2019;29(10):5298-5306.